Replagal Enzyme Replacement Therapy for Children With Fabry Disease

NCT00084084 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shire